HLA-A and uveal melanoma: The binding of the TCR arm to HLA-A*02:01-positive uveal melanoma cells and CD3 scFvs provides CD3 agonism, activating polyclonal T cells resulting in the release of inflammatory cytokines and cytolytic proteins and the subsequent clearance of tumor cells.